| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 85.26B | 85.34B | 85.21B | 82.05B | 85.33B | 78.65B |
| Gross Profit | 18.07B | 18.36B | 18.39B | 18.04B | 18.76B | 17.40B |
| EBITDA | 2.88B | 2.92B | 3.31B | 3.99B | 3.88B | 3.29B |
| Net Income | 759.00M | 991.00M | 1.10B | 1.31B | 1.48B | 939.00M |
Balance Sheet | ||||||
| Total Assets | 103.15B | 100.26B | 102.23B | 103.29B | 102.16B | 98.30B |
| Cash, Cash Equivalents and Short-Term Investments | 16.54B | 12.95B | 14.74B | 18.68B | 21.78B | 22.22B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 27.66B | 22.42B | 25.94B | 28.11B | 29.26B | 25.52B |
| Stockholders Equity | 75.48B | 77.84B | 76.28B | 75.18B | 72.90B | 72.78B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.21B | -1.69B | -2.07B | 2.46B | 2.33B |
| Operating Cash Flow | 0.00 | -731.00M | -423.00M | -210.00M | 3.67B | 3.58B |
| Investing Cash Flow | 0.00 | -1.75B | -2.75B | -345.00M | -874.00M | -1.41B |
| Financing Cash Flow | 0.00 | -818.00M | -817.00M | -863.00M | -816.00M | -815.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥190.81B | 13.17 | ― | 3.41% | 3.85% | 41.80% | |
73 Outperform | ¥487.56B | 13.38 | 8.51% | 2.25% | 2.19% | 23.96% | |
73 Outperform | ¥31.91B | 9.17 | ― | 3.56% | 3.46% | 102.90% | |
67 Neutral | ¥65.77B | 28.00 | 1.61% | 2.27% | 0.39% | -21.22% | |
67 Neutral | ¥18.13B | 12.04 | ― | 2.30% | 0.91% | 29.68% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
53 Neutral | ¥27.56B | 27.94 | ― | 2.94% | 0.15% | -10.36% |